Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction

Kidney International

Volumn 88, Issue 2, 2015, Pages 276-285

  Papista, Christina ^a,b,c   Lechner, Sebastian ^a,b,c   Ben Mkaddem, Sanae ^a,b,c   Lestang, Marie Bénédicte ^a,b,c   Abbad, Lilia ^a,b,c   Bex Coudrat, Julie ^a,b,c   Pillebout, Evangéline ^d   Chemouny, Jonathan M ^a,b,c   Jablonski, Mathieu ^e   Flamant, Martin ^a,b,c,f   Daugas, Eric ^a,b,c,e   Vrtovsnik, François ^a,b,c,e   Yiangou, Minas ^g   Berthelot, Laureline ^a,b,c   Monteiro, Renato C ^a,b,c,h  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CNRS   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e AURA Paris Plaisance   (France)

^f Service du Professeur JC Willer   (France)

^g ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^h BICHAT HOSPITAL   (France)

Author keywords

glomerulonephritis; IgA nephropathy; inflammation; mucosal immunity

Indexed keywords

CD71 ANTIGEN; CD89 ANTIGEN; GLIADIN; GLIADIN ANTIBODY; GLUTEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A1; LYMPHOCYTE ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UNCLASSIFIED DRUG; FC RECEPTOR; FC(ALPHA) RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN A; LEUKOCYTE ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TFRC PROTEIN, MOUSE; TRANSFERRIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; COMPLEMENT DEPOSITION; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GLUTEN FREE DIET; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; IMMUNOGLOBULIN PRODUCTION; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; ANIMAL; ATROPHY; BLOOD; DIET THERAPY; DISEASE MODEL; ENTERITIS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; ANTIGENS, CD; ATROPHY; DIET, GLUTEN-FREE; DISEASE MODELS, ANIMAL; ENTERITIS; GLIADIN; GLOMERULONEPHRITIS, IGA; GLUTENS; GTP-BINDING PROTEINS; HEMATURIA; IMMUNOGLOBULIN A; INTESTINAL MUCOSA; MALE; MICE; PROTEINURIA; RECEPTORS, FC; RECEPTORS, TRANSFERRIN; TRANSGLUTAMINASES;

EID: 84938555781     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.94     Document Type: Article

References (44)

1. Berger J, Hinglais N. Les dépôts intercapillaires d'IgA-IgG. J Urol Néphol 1968; 74: 694-695
2. Galla JH. IgA nephropathy. Kidney Int 1995; 47: 377-387
3. Novak J, Julian BA, Tomana M et al. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 2008; 28: 78-87
4. Valentijn RM, Radl J, Haaijman JJ et al. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int 1984; 26: 760-766
5. Barratt J, Eitner F, Feehally J et al. Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time?. Nephrol Dial Transplant 2009; 24: 3620-3623
6. Tanaka M, Seki G, Someya T et al. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy. Clin Dev Immunol 2011; 2011: 470803
7. Berthelot L, Papista C, Maciel TT et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 2012; 209: 793-806
8. Launay P, Grossetete B, Arcos-Fajardo M et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy. Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J Exp Med 2000; 191: 1999-2009
9. Vuong MT, Hahn-Zoric M, Lundberg S et al. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy. Kidney Int 2010; 78: 1281-1287
10. Berthoux F, Suzuki H, Thibaudin L et al. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 2012; 23: 1579-1587
11. Daha MR, Van Kooten C. Deposition of IgA in primary IgA nephropathy: it takes at least four to tango. Nephrol Dial Transplant 2013; 28: 794-797
12. Coppo R, Mazzucco G, Martina G et al. Gluten-induced experimental IgA glomerulopathy. Lab Invest 1989; 60: 499-506
13. Coppo R, Amore A, Roccatello D. Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 1992; 2: S173-S180
14. Papista C, Berthelot L, Monteiro RC. Dysfunctions of the IgA system: a common link between intestinal and renal diseases. Cell Mol Immunol 2011; 8: 126-134
15. Smerud HK, Fellstrom B, Hallgren R et al. Gluten sensitivity in patients with IgA nephropathy. Nephrol Dial Transplant 2009; 24: 2476-2481
16. Coppo R. The intestine-renal connection in IgA nephropathy. Nephrol Dial Transplant 2014; 0: 1-7
17. Amore A, Emancipator SN, Roccatello D et al. Functional consequences of the binding of gliadin to cultured rat mesangial cells: bridging immunoglobulin A to cells and modulation of eicosanoid synthesis and altered cytokine production. Am J Kidney Dis 1994; 23: 290-301
18. Sato M, Kojima H, Takayama K et al. Glomerular deposition of food antigens in IgA nephropathy. Clin Exp Immunol 1988; 73: 295-299
19. Yap HK, Sakai RS, Woo KT et al. Detection of bovine serum albumin in the circulating IgA immune complexes of patients with IgA nephropathy. Clin Immunol Immunopathol 1987; 43: 395-402
20. Papista C, Gerakopoulos V, Kourelis A et al. Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics. Lab Invest 2012; 92: 625-635
21. Kovacs T, Kun L, Schmelczer M et al. Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy?. I. Study of intestinal permeability. Am J Nephrol 1996; 16: 500-505
22. Rostoker G, Delchier JC, Chaumette MT. Increased intestinal intraepithelial T lymphocytes in primary glomerulonephritis: a role of oral tolerance breakdown in the pathophysiology of human primary glomerulonephritides?. Nephrol Dial Transplant 2001; 16: 513-517
23. Rostoker G, Terzidis H, Petitphar M et al. Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis. Clin Exp Immunol 1992; 90: 305-311
24. Oortwijn BD, Van Der Boog PJ, Roos A et al. A pathogenic role for secretory IgA in IgA nephropathy. Kidney Int 2006; 69: 1131-1138
25. Sato M, Takayama K, Wakasa M et al. Estimation of circulating immune complexes following oral challenge with cow's milk in patients with IgA nephropathy. Nephron 1987; 47: 43-48
26. Lu J, Marjon KD, Marnell LL et al. Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein. Proc Natl Acad Sci USA 2011; 108: 4974-4979
27. Mestecky J, Raska M, Julian BA et al. IgA nephropathy: molecular mechanisms of the disease. Annu Rev Pathol 2013; 8: 217-240
28. Smerud HK, Barany P, Lindstrom K et al. New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria. Nephrol Dial Transplant 2011; 26: 3237-3242
29. Kamata T, Nogaki F, Fagarasan S et al. Increased frequency of surface IgA-positive plasma cells in the intestinal lamina propria and decreased IgA excretion in hyper IgA (HIGA) mice, a murine model of IgA nephropathy with hyperserum IgA. J Immunol 2000; 165: 1387-1394
30. Harper SJ, Pringle JH, Wicks ACB et al. Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int 1994; 45: 836-844
31. Fornasieri A, Sinico RA, Maldifassi P et al. IgA-antigliadin antibodies in IgA mesangial nephropathy. Br Med J 1987; 295: 78-80
32. Pasternack A, Collin P, Mustonen J et al. Glomerular IgA deposits in patients with celiac disease. Clin Nephrol 1990; 34: 56-60
33. Collin P, Syrjanen J, Partanen J et al. Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol 2002; 97: 2572-2576
34. Pierucci A, Fofi C, Bartoli B et al. Antiendomysial antibodies in Berger's disease. Am J Kidney Dis 2002; 39: 1176-1182
35. Welander A, Prutz KG, Fored M et al. Increased risk of end-stage renal disease in individuals with coeliac disease. Gut 2012; 61: 64-68
36. Welander A, Sundelin B, Fored M et al. Increased risk of IgA nephropathy among individuals with celiac disease. J Clin Gastroenterol 2013; 47: 678-683
37. Moeller S, Canetta PA, Taylor AK et al. Lack of serologic evidence to link IgA nephropathy with celiac disease or immune reactivity to gluten. PLoS One 2014; 9: e94677
38. Coppo R, Roccatello D, Amore A et al. Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol 1990; 33: 72-86
39. Duchez S, Amin R, Cogne N et al. Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation. Proc Natl Acad Sci USA 2010; 107: 3064-3069
40. Lebron JA, Bennett MJ, Vaughn De et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998; 93: 111-123
41. Maurano F, Siciliano RA, De Giulio B et al. Intranasal administration of one alpha gliadin can downregulate the immune response to whole gliadin in mice. Scand J Immunol 2001; 53: 290-295
42. Kourelis A, Zinonos I, Kakagianni M et al. Validation of the dorsal air pouch model to predict and examine immunostimulatory responses in the gut. J Appl Microbiol 2010; 108: 274-284
43. Bethune MT, Borda JT, Ribka E et al. A non-human primate model for gluten sensitivity. PLoS One 2008; 3: e1614
44. Jacob L, Lety MA, Monteiro RC et al. Altered cell-surface protein(s), crossreactive with DNA, on spleen cells of autoimmune lupic mice. Proc Natl Acad Sci USA 1987; 84: 1361-1363